Connor, Clark & Lunn Investment Management (CC&L)
PRVA icon

Connor, Clark & Lunn Investment Management (CC&L)’s Privia Health PRVA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-68,919
Closed -$1.9M – 1458
2023
Q1 		$1.9M Buy
+68,919
New +$1.82M 0.01% 566

Other funds holding PRVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s PRVA Position: Q2 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Privia Health (PRVA) in Q2 2023, closing a stake of 68,919 shares — an estimated $1.9M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in PRVA in Q1 2023 and held it in 1 quarter. The position peaked at $1.9M in Q1 2023. 234 funds tracked by Wall St. Rank hold PRVA as of Q2 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Privia Health position as of Q2 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 68,919 Privia Health shares in Q2 2023, an estimated $1.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Privia Health in Q1 2023 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Privia Health position peaked at $1.9M in Q1 2023.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q2 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2023, filed 10 Aug 2023.